These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 31472471)
1. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation. Moi D; Nocentini A; Deplano A; Balboni G; Supuran CT; Onnis V Eur J Med Chem; 2019 Nov; 182():111638. PubMed ID: 31472471 [TBL] [Abstract][Full Text] [Related]
2. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors. Nocentini A; Moi D; Balboni G; Onnis V; Supuran CT Bioorg Chem; 2018 Apr; 77():293-299. PubMed ID: 29421705 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties. Congiu C; Onnis V; Deplano A; Balboni G; Ceruso M; Supuran CT Bioorg Med Chem; 2015 Sep; 23(17):5619-25. PubMed ID: 26233796 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy. Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024 [TBL] [Abstract][Full Text] [Related]
7. Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives. De Monte C; Carradori S; Secci D; D'Ascenzio M; Vullo D; Ceruso M; Supuran CT Eur J Med Chem; 2014 Sep; 84():240-6. PubMed ID: 25019479 [TBL] [Abstract][Full Text] [Related]
8. Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors. Nocentini A; Moi D; Deplano A; Osman SM; AlOthman ZA; Balboni G; Supuran CT; Onnis V Eur J Med Chem; 2020 Jan; 186():111896. PubMed ID: 31784185 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Winum JY; Pastorekova S; Jakubickova L; Montero JL; Scozzafava A; Pastorek J; Vullo D; Innocenti A; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(3):579-84. PubMed ID: 15664816 [TBL] [Abstract][Full Text] [Related]
10. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors. Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II. Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111 [TBL] [Abstract][Full Text] [Related]
13. Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors. Pustenko A; Nocentini A; Balašova A; Alafeefy A; Krasavin M; Žalubovskis R; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):245-254. PubMed ID: 31790605 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety. Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors. Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
17. Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII. Ibrahim HS; Abou-Seri SM; Tanc M; Elaasser MM; Abdel-Aziz HA; Supuran CT Eur J Med Chem; 2015 Oct; 103():583-93. PubMed ID: 26408817 [TBL] [Abstract][Full Text] [Related]
18. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors. Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419 [TBL] [Abstract][Full Text] [Related]
19. 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors. Cornelio B; Laronze-Cochard M; Miambo R; De Grandis M; Riccioni R; Borisova B; Dontchev D; Machado C; Ceruso M; Fontana A; Supuran CT; Sapi J Eur J Med Chem; 2019 Aug; 175():40-48. PubMed ID: 31071549 [TBL] [Abstract][Full Text] [Related]
20. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]